Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 11.4B | 10.6B | 10.5B | 10.3B |
Cost of revenue | 6.6B | 6.3B | 6.2B | 6.1B |
Gross profit | 4.8B | 4.3B | 4.3B | 4.2B |
Operating expense | ||||
Research & development | 374M | 346M | 339M | 331M |
Selling general and admin | 2.2B | 2.1B | 2.1B | 2.2B |
Other operating expenses | — | — | — | — |
Operating income | 2.2B | 1.9B | 1.9B | 1.7B |
Non operating interest income | ||||
Income | 227M | 277M | 295M | 279M |
Expense | 317M | 356M | 354M | 363M |
Other income expense | -214M | -61M | -72M | -19M |
Pretax income | 1.9B | 1.7B | 1.8B | 1.6B |
Tax provision | 150M | 99M | 128M | 281M |
Net income | 1.8B | 1.6B | 1.6B | 1.3B |
Basic EPS | — | 4.3 | 4.1 | 3.5 |
Diluted EPS | — | 4.3 | 4.0 | 3.5 |
Basic average shares | — | 382M | 382M | 382M |
Diluted average shares | — | 384M | 383M | 384M |
EBITDA | 3.2B | 2.9B | 3.0B | 2.8B |
Net income from continuing op. | 1.8B | 1.6B | 1.6B | 1.3B |
Minority interests | 6M | 0 | -6M | -4M |
Preferred stock dividends | — | — | — | — |